The elevated insulin concentration in the insulin-resistance-inducing protocol led to prolonged activation of ERK, which explains the sustained phosphorylation of ERK1/2 kinase substrates in the control (Fig. 3B). This evidence concerns the gene MAPK1 and Insulin resistance.